Can India be a clinical-trial hub? While drug makers are upbeat, it should not repeat past mistakes.

[ad_1]

Clinical trials were emerging as a booming sector in the early part of the last decade. But following guideline violations, a court-ordered suspension of clinical trials dimmed the sector’s prospects. After a new set of stringent rules came into force in 2019, the industry feels there are compelling reasons to go full throttle on clinical trials. But is India ready?

[ad_2]

Source link